| 000 | 01702 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516165329.0 | ||
| 264 | 0 | _c20140626 | |
| 008 | 201406s 0 0 eng d | ||
| 022 | _a1898-4002 | ||
| 024 | 7 |
_a10.2478/v10039-012-0074-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRatajczak-Wrona, W | |
| 245 | 0 | 0 |
_aThe role of MAP kinases in the induction of iNOS expression in neutrophils exposed to NDMA: the involvement transcription factors. _h[electronic resource] |
| 260 |
_bAdvances in medical sciences _c2013 |
||
| 300 |
_a265-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aDimethylnitrosamine _xpharmacology |
| 650 | 0 | 4 |
_aGene Expression Regulation, Enzymologic _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJNK Mitogen-Activated Protein Kinases _xmetabolism |
| 650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase 7 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNeutrophils _xdrug effects |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xmetabolism |
| 650 | 0 | 4 |
_aTranscription Factor AP-1 _xmetabolism |
| 650 | 0 | 4 |
_aTranscription Factor RelA _xmetabolism |
| 650 | 0 | 4 |
_aXenobiotics _xpharmacology |
| 650 | 0 | 4 |
_ap38 Mitogen-Activated Protein Kinases _xmetabolism |
| 700 | 1 | _aJablonska, E | |
| 700 | 1 | _aGarley, M | |
| 700 | 1 | _aJablonski, J | |
| 700 | 1 | _aRadziwon, P | |
| 700 | 1 | _aIwaniuk, A | |
| 773 | 0 |
_tAdvances in medical sciences _gvol. 58 _gno. 2 _gp. 265-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2478/v10039-012-0074-y _zAvailable from publisher's website |
| 999 |
_c23037726 _d23037726 |
||